Wright gets US nod for Allomatrix line:
This article was originally published in Clinica
Orthopaedic medical device company Wright Medical has gained US market clearance for its Allomatrix family of allograft bone void fillers. Following FDA clearance of its Allomatrix injectable putty in March this year, the company has now been given the go-ahead to sell its Allomatrix C, Allomatrix Custom, and Allomatrix DR bone graft putties that contain demineralised bone matrix (DBM) and specific volumes and configurations of donor matched, cancellous bone chips. The Arlington, Tennessee firm claims that its Allomatrix products and Osteoset 2 DBM bone graft substitute are the only commercially available, FDA-cleared products which contain DBM.
You may also be interested in...
Following hot on the heels of its Rapidly Manufactured Ventilator Specification document, the UK’s regulator has issued another speedy regulatory permit for fast production of respiratory assist devices.
Which drug candidates represent hope, and which hype? The Scrip team examine the COVID-19 pipeline, lessons from China, and some long term impacts on the sector.
China insists there is no double standard and won’t tolerate any quality issues in its centralized procurement process.